Bilibili to Report Second Quarter 2020 Financial Results on Wednesday, August 26, 2020
SHANGHAI, China, Aug. 11, 2020 (GLOBE NEWSWIRE) — Bilibili Inc. (“Bilibili” or the “Company”) (NASDAQ: BILI), a leading online entertainment […]
Prevail Therapeutics Reports Second Quarter 2020 Financial Results and Business Highlights
Preliminary Data Demonstrates Normalization of CSF GBA1 Enzyme Activity in Parkinson’s Disease with GBA1 Mutations and Neuronopathic Gaucher Disease PatientsCompany […]
Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2020
CAMBRIDGE, Mass., Aug. 11, 2020 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that […]
CentoMD® Update Reveals Further Insights Into Rare Diseases
CAMBRIDGE, Mass., and ROSTOCK and BERLIN, Aug. 11, 2020 (GLOBE NEWSWIRE) — Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused […]
Generation Bio Reports Business Updates and Second Quarter 2020 Financial Results
CAMBRIDGE, Mass., Aug. 11, 2020 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a […]
Affimed Reports Second Quarter 2020 Financial Results and Operational Progress
Continued progress in the AFM13 pTCL REDIRECT monotherapy studyAFM24 is recruiting patients in cohort 2 of a Phase 1/2a clinical […]
Fennec Pharmaceuticals Receives Complete Response Letter from the FDA for its New Drug Application for PEDMARK™ to Prevent Ototoxicity Associated with Cisplatin in Pediatric Patients with Localized, Non-Metastatic, Solid Tumors
~ No Clinical Safety or Efficacy Issues Identified, and No Requirement for Further Clinical Data ~~ FDA Pre-Approval Inspection has […]
BioNTech Announces Second Quarter 2020 Financial Results and Corporate Progress
Pivotal Phase 2b/3 trial for BNT162 vaccine program against COVID-19 initiated with first clinical results expected as early as October […]
eGain Announces Positive Preliminary Financial Results for Fiscal 2020 Fourth Quarter and Full Year
SUNNYVALE, Calif., Aug. 11, 2020 (GLOBE NEWSWIRE) — eGain (NASDAQ: EGAN), a leading provider of omnichannel customer engagement solutions, today […]
Catalyst Pharmaceuticals Announces Notice of Allowance of a U.S. Patent Application for “Methods of Administering 3,4-Diaminopyridine”
CORAL GABLES, Fla., Aug. 11, 2020 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused […]
